✉ Email this page to a colleague
« Back to Dashboard
Iclaprim is an investigational drug.
There have been 5 clinical trials for Iclaprim. The most recent clinical trial was a Phase 3 trial, which was initiated on March 1st 2006.
The most common disease conditions in clinical trials are Skin Diseases, Bacterial, Infections, and Soft Tissue Infections. The leading clinical trial sponsors are Arpida AG, Motif Bio, and [disabled in preview].
Recent Clinical Trials for Iclaprim
|Phase 3 Study to Evaluate Safety and Efficacy of Iclaprim Versus Vancomycin for ABSSSI: REVIVE-1||Motif Bio||Phase 3|
|Phase 3 Study to Evaluate Safety and Efficacy of Iclaprim Versus Vancomycin for ABSSSI: REVIVE-2||Motif Bio||Phase 3|
|Clinical Efficacy of Intravenous Iclaprim Versus Vancomycin in the Treatment of Hospital-Acquired, Ventilator-Associated, or Health-Care-Associated Pneumonia||Arpida AG||Phase 2|